June 1, 2019 “Advanced breast cancer in pre-menopausal women can be very aggressive. It is important and encouraging to see a targeted therapy that significantly increases survival for younger women with this disease,” said ASCO® Expert Harold J. Burstein, MD, PhD. CHICAGO – The international, randomized phase III MONALEESA-7 trial found that adding ribociclib...
Pro zobrazení tohoto obsahu je třeba být přihlášen.